Commerce and Genetic Diagnostics

The revolution in molecular biology and molecular genetics has begun to reveal the sequence of events that links genes and disease. As a result of activities such as the Human Genome Project, a parallel revolution in technology is bringing nearer to hand the possibility of readily available genetic...

Full description

Saved in:
Bibliographic Details
Published in:The Hastings Center report 1995-05, Vol.25 (3), p.S15-S18
Main Author: Silverman, Paul H.
Format: Article
Language:English
Subjects:
Abortion, Eugenic
Advertising as Topic
Bioethics
Biotechnology
Business ethics
Communicable Diseases
Diagnosis, Laboratory
DNA
Drug Industry
Economic aspects
Economics
Entrepreneurship
Finance
Forensic genetics
Forensic Medicine
Genetic Counseling
Genetic diseases
Genetic Diseases, Inborn
Genetic screening
Genetic Services
Genetic Testing
Genetics
Human genetics
Humans
Industry
Industry profiles
Laboratory diagnosis
Medical ethics
Medical genetics
Medical technology
Molecular genetics
Neoplasms
Pharmacogenetics
Pharmacogenomics
Physician Self-Referral
Physicians
Prenatal Diagnosis
Reproductive Techniques, Assisted
Research Personnel
Self-Help Groups
Services
Social Change
Special Supplement: Public Priorities for Genetic Services
Start up firms
Tay Sachs disease
United States
Universities
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The revolution in molecular biology and molecular genetics has begun to reveal the sequence of events that links genes and disease. As a result of activities such as the Human Genome Project, a parallel revolution in technology is bringing nearer to hand the possibility of readily available genetic diagnostics. Genetic testing services have begun to move out of the academic medical centers and into the private enterprise arena. Under these circumstances it is important to understand the factors affecting the availability and application of this powerful predictive tool in a for-profit mode. How does the marketplace encourage or discourage genetic testing? Will the same market influences that generate pharmaceutical sales be operating to "sell" genetic tests?
ISSN:0093-0334
1552-146X
DOI:10.2307/3562125